pharma
dog
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
News
when
Latest
Archive
by source
All Sources
Sources Page
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Marketed
ARIPIPRAZOLE
ARIPIPRAZOLE (ARIPIPRAZOLE)
Autism Spectrum Disorder (ASD)
Otsuka America Pharmaceutical Inc
0
catalysts
Preclinical
ARM-201
Facioscapulohumeral Muscular Dystrophy (FSHD)
Armatus Bio LLC
0
catalysts
Preclinical
ARR-002
Endometrial Cancer
Aarvik Therapeutics Inc
0
catalysts
Phase 1
ART-101
← prev
page 58 of 271
next →
131
Pain
89
Neurology
1
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Archeus Technologies Inc
0
catalysts
Phase 1
ART-26.12
Chemotherapy Induced Peripheral Neuropathy
$ARTL
ARTELO BIOSCIENCES, INC.
0
catalysts
Preclinical
ART-4
Alagille Syndrome
Arnatar Therapeutics Inc
0
catalysts
Phase 1
ART-4215
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
Artios Pharma Ltd
0
catalysts
Phase 2
ART-6043
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
Artios Pharma Ltd
0
catalysts
Phase 2
ARTHEx-01
Myotonic Dystrophy
ARTHEx Biotech SL
0
catalysts
ARTICAINE
ARTICAINE (ARTICAINE HYDROCHLORIDE AND EPINEPHRINE)
DEPROCO
0
catalysts
Phase 2
ARTS-021
Endometrial Cancer
Avenzo Therapeutics Inc
0
catalysts
Phase 2
ARTS-023
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
Avenzo Therapeutics Inc
0
catalysts
Phase 2
ARV-806
Colorectal Cancer
$ARVN
ARVINAS, INC.
0
catalysts
Phase 1
ARX-305
Renal Cell Carcinoma
Ambrx Biopharma Inc
0
catalysts
Phase 1
ARX-517
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Ambrx Biopharma Inc
0
catalysts
ARYNTA
ARYNTA (LISDEXAMFETAMINE DIMESYLATE)
Azurity Pharmaceuticals Inc
0
catalysts
Preclinical
AS-00491
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
$AAPG
ASCENTAGE PHARMA GROUP INTERNATIONAL
0
catalysts
Preclinical
AS-202
Amyotrophic Lateral Sclerosis
$TAK
TAKEDA PHARMACEUTICAL CO LTD
0
catalysts
Phase 2
ASC-30
Obesity
Ascletis Pharma Inc
0
catalysts
Preclinical
ASC-35
Obesity
Ascletis Pharma Inc
0
catalysts
Preclinical
ASC-36
Obesity
Ascletis Pharma Inc
0
catalysts
Preclinical
ASC-37
Obesity
Ascletis Pharma Inc
0
catalysts
Preclinical
ASC-39
Obesity
Ascletis Pharma Inc
0
catalysts
Phase 1
ASC-47
Obesity
Gannex Pharma Co Ltd
0
catalysts
Phase 1
ASC-50
Plaque Psoriasis (Psoriasis Vulgaris)
Ascletis Pharma Inc
0
catalysts
Phase 1
ASC-60
Acne Vulgaris
$SGMT
Sagimet Biosciences Inc.
0
catalysts
Phase 2
ASC-618
Hemophilia A (Factor VIII Deficiency)
ASC Therapeutics Inc
0
catalysts
Phase 1
ASC-930
Graft Versus Host Disease (GVHD)
ASC Therapeutics Inc
0
catalysts
Preclinical
ASD-004
Breast Cancer
Asdera LLC
0
catalysts
Preclinical
ASD-005
Alzheimer's Disease
Asdera LLC
0
catalysts
